• In late June 2026, Amcor announced a collaboration with U.K.-based startup Kelpi to assess seaweed-based, bio-derived coating technologies for its AmFiber™ fiber packaging, targeting stronger barrier performance and compatibility with recycling streams while reducing reliance on fossil fuel feedstocks.
• This partnership highlights how Amcor is trying to pair its global R&D scale with Kelpi’s seaweed platform to broaden renewable, fiber-based packaging solutions for consumer goods customers and support a more circular packaging economy.
• Next, we’ll examine how integrating Kelpi’s seaweed-based coatings into Amcor’s AmFiber™ platform could influence its existing investment narrative.

AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Amcor Investment Narrative Recap

To be comfortable owning Amcor today, you need to believe the Berry integration, portfolio reshaping and sustainability-led innovation can lift earnings despite soft volumes, high leverage and underperforming North American beverage. The Kelpi seaweed-coating collaboration reinforces the sustainability catalyst but does not materially change near term priorities, which still center on hitting synergy targets, improving margins and progressing asset reviews without pressuring already thin profit margins or cash generation.

Among recent developments, the completed divestment of ESE World to Pacific Avenue Capital Partners is most relevant, as it shows Amcor actively pruning lower growth or less scalable assets while refining its portfolio. Together with moves like the Kelpi collaboration, it frames a story of focusing on higher value packaging solutions and freeing up resources, but also highlights the execution risk around selling or restructuring roughly US$2.5 billion of under-review sales without diluting future profitability.

Yet behind the sustainability story, investors should also be aware of the concentration of risk around high leverage and the large portfolio under review...

Amcor's narrative projects $23.9 billion revenue and $1.6 billion earnings by 2029.

Uncover how Amcor's forecasts yield a $48.21 fair value, a 7% upside to its current price.

Exploring Other Perspectives

Before this Kelpi news, the most optimistic analysts were assuming Amcor could reach about US$25.8 billion in revenue and US$2.3 billion in earnings by 2028, which is a far more ambitious path than the consensus narrative and leans heavily on smooth Berry synergies and faster growth in premium categories that are now showing softer demand.

Explore 6 other fair value estimates on Amcor - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Amcor research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Amcor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amcor's overall financial health at a glance.

Searching For A Fresh Perspective?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.